119 related articles for article (PubMed ID: 810201)
1. Periosteal new bone formation developing during haemodialysis for chronic renal failure.
Ritchie WG; Winney RJ; Davison AM; Robson JS
Br J Radiol; 1975 Aug; 48(572):656-61. PubMed ID: 810201
[TBL] [Abstract][Full Text] [Related]
2. Periosteal new bone formation in chronic renal failure.
Parnell AP; Simpson W; Ward MK
Clin Radiol; 1989 Sep; 40(5):490-3. PubMed ID: 2507211
[TBL] [Abstract][Full Text] [Related]
3. Periosteal new bone formation in hyperparathyroidism associated with renal failure.
Heath DA; Martin DJ
Br J Radiol; 1970 Aug; 43(512):517-21. PubMed ID: 5433359
[No Abstract] [Full Text] [Related]
4. Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Relationship to osteosclerosis, osteitis fibrosa, and osteoid excess.
Meema HE; Oreopoulos DG; Rabinovich S; Husdan H; Rapoport A
Radiology; 1974 Mar; 110(3):513-22. PubMed ID: 4204516
[No Abstract] [Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Periosteal new bone in uraemic osteodystrophy.
Tamarozzi R; Bedani PL; Scutellari PN; Orzincolo C; Pinna L; Farinelli A
Skeletal Radiol; 1984; 11(1):50-3. PubMed ID: 6710181
[TBL] [Abstract][Full Text] [Related]
7. Periosteal new bone in patients on intermittent haemodialysis: an early indicator of aluminium-induced osteomalacia?
Chambers SE; Winney RJ
Clin Radiol; 1985 Mar; 36(2):163-8. PubMed ID: 4064494
[TBL] [Abstract][Full Text] [Related]
8. [Pseudotumoral progression in a case of periosteal ossification of the femur].
Boero G; Bossi G
Minerva Med; 1977 May; 68(23):1587-92. PubMed ID: 404597
[TBL] [Abstract][Full Text] [Related]
9. 1-Alpha-hydroxy vitamin D in dialysis bone disease: radiological changes after 6 and 12 months of treatment.
Robinson PJ; Walker GS; Peacock M; McLachlan MS; Davison AM
Clin Radiol; 1982 Jan; 33(1):9-17. PubMed ID: 6802550
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histological, and chemical characterization of ectopic calcification in dialyzed and non-dialyzed patients.
Portigliatti Barbos M; Cadario A; Canavese C; Pavan I
Ital J Orthop Traumatol; 1991 Dec; 17(4):523-32. PubMed ID: 1816158
[TBL] [Abstract][Full Text] [Related]
11. Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol.
Hansen D; Rasmussen K; Pedersen SM; Rasmussen LM; Brandi L
Nephrol Dial Transplant; 2012 Jun; 27(6):2263-9. PubMed ID: 22140123
[TBL] [Abstract][Full Text] [Related]
12. [Phosphate binding therapy].
Kinugasa E; Ito H
Nihon Rinsho; 2004 May; 62 Suppl 5():379-83. PubMed ID: 15197949
[No Abstract] [Full Text] [Related]
13. Maxillary brown tumor of secondary hyperparathyroidism in a hemodialysis patient.
Weiss RR; Schoeneman MJ; Primack W; Rozycki D; Bennett B; Greifer I
JAMA; 1980 May; 243(19):1929-30. PubMed ID: 7365977
[No Abstract] [Full Text] [Related]
14. Hyperparathyroid bone disease in diabetic renal failure.
Cundy TF; Humphreys S; Watkins PJ; Parsons V
Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients].
Fünfstück R; Günther K; Tietz U; Brandstädt A; Stein G; Hartwich R
Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021
[TBL] [Abstract][Full Text] [Related]
16. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis].
Kuhlencordt F; Augustin HJ; Kruse HP
Dtsch Med Wochenschr; 1970 Oct; 95(42):2122-5. PubMed ID: 4990903
[No Abstract] [Full Text] [Related]
17. Secondary hyperparathyroidism in chronic renal failure.
Malmaeus J
Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
[TBL] [Abstract][Full Text] [Related]
18. Improvement in the anemia of hemodialyzed patients following subtotal parathyroidectomy. Evidence for the role of secondary hyperparathyroidism in the etiology of the anemia of chronic renal failure.
Shasha SM; Better OS; Winaver J; Chaimovitz C; Barzilai A; Erlik D
Isr J Med Sci; 1978 Mar; 14(3):328-32. PubMed ID: 640816
[TBL] [Abstract][Full Text] [Related]
19. Severe hyperparathyroidism despite paricalcitol therapy: one-year follow-up.
Shuja SB; Raja RM
Adv Perit Dial; 2003; 19():231-5. PubMed ID: 14763069
[TBL] [Abstract][Full Text] [Related]
20. [Outcome of osseous lesions of hyperparathyroidism in a patient with chronic renal failure treated with high doses of vitamin D].
Verberckmoes R; Tanghe W; Michielsen P; Vandenbroucke J
J Urol Nephrol (Paris); 1970 Sep; 76(9):790-7. PubMed ID: 5482082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
